机译:Zanubrutinib对慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者免疫细胞的影响
Nanjing Med Univ Jiangsu Prov Hosp Affiliated Hosp 1 Dept Hematol Nanjing 210029 Jiangsu;
Nanjing Med Univ Jiangsu Prov Hosp Affiliated Hosp 1 Dept Hematol Nanjing 210029 Jiangsu;
Nanjing Med Univ Jiangsu Prov Hosp Affiliated Hosp 1 Dept Hematol Nanjing 210029 Jiangsu;
Nanjing Med Univ Jiangsu Prov Hosp Affiliated Hosp 1 Dept Hematol Nanjing 210029 Jiangsu;
Nanjing Med Univ Jiangsu Prov Hosp Affiliated Hosp 1 Dept Hematol Nanjing 210029 Jiangsu;
Nanjing Med Univ Jiangsu Prov Hosp Affiliated Hosp 1 Dept Hematol Nanjing 210029 Jiangsu;
Nanjing Med Univ Jiangsu Prov Hosp Affiliated Hosp 1 Dept Hematol Nanjing 210029 Jiangsu;
Nanjing Med Univ Jiangsu Prov Hosp Affiliated Hosp 1 Dept Hematol Nanjing 210029 Jiangsu;
Nanjing Med Univ Jiangsu Prov Hosp Affiliated Hosp 1 Dept Hematol Nanjing 210029 Jiangsu;
Nanjing Med Univ Jiangsu Prov Hosp Affiliated Hosp 1 Dept Hematol Nanjing 210029 Jiangsu;
chronic lymphocytic leukemia; dynamics; immune cells; small lymphocytic lymphoma; zanubrutinib;
机译:Zanubrutinib对慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者免疫细胞的影响
机译:Zanubrutinib对慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者免疫细胞的影响
机译:长期易含碱治疗对慢性淋巴细胞白血病患者循环免疫细胞的影响
机译:通过来自体外活化B细胞慢性淋巴细胞白血病细胞超深序的De Novo IghV突变检测:活化诱导的脱氨酶功能的证据
机译:绝经后妇女慢性淋巴细胞白血病和小淋巴细胞淋巴瘤发生率的危险因素:妇女健康倡议(WHI)研究
机译:使用BTK抑制剂zanubrutinib治疗复发/难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤:2期单臂多中心研究
机译:用BTK抑制剂Zanubrutinib的复发/难治性慢性淋巴细胞白血病/小淋巴细胞淋巴瘤:2阶段2,单臂,多中心研究